Novel forms of lipodystrophy: Why should we care?

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2142-2145

  Rother, Kristina I ^a   Brown, Rebecca J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARICITINIB; LEPTIN; RECOMBINANT LEPTIN;

ACQUIRED GENERALIZED LIPODYSTROPHY; ACQUIRED PARTIAL LIPODYSTROPHY; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; CHRONIC NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CLINICAL FEATURE; COMORBIDITY; CONGENITAL GENERALIZED LIPODYSTROPHY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DYSTROPHY; FAMILIAL PARTIAL LIPODYSTROPHY; GENE MUTATION; GENETIC COUNSELING; HEREDITY; HIV ASSOCIATED LIPODYSTROPHY; HORMONE SUBSTITUTION; HUMAN; JUVENILE DERMATOMYOSITIS; LIPODYSTROPHY; OBESITY; PARTIAL LIMB LIPODYSTROPHY; PATHOPHYSIOLOGY; PROTEIN HOMEOSTASIS; REVIEW; SYMPTOMATOLOGY; COMPLICATION; FEMALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPODYSTROPHY;

EID: 84885977479     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0561     Document Type: Review

References (16)

1. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313-3325
2. Arioglu E, Rother KI, Reitman ML, Premkumar A, Taylor SI. Lipoatrophy syndromes: when 'too little fat' is a clinical problem. Pediatr Diabetes 2000;1:155-168
3. Handelsman Y, Oral EA, Bloomgarden ZT, et al. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract 2013;19: 107-116
4. Dutour A, Roll P, Gaborit B, et al. High prevalence of laminopathies among patients with metabolic syndrome. Hum Mol Genet 2011;20:3779-3786
5. Strickland LR, Guo F, Lok K, Garvey WT. Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype. Diabetes Care 2013;36:2247-2253
6. Domingo P, Estrada V, López-Aldeguer J, Villaroya F, Martínez E. Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev 2012;14:112-123
7. Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit b type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012;64: 895-907
8. Garg A, Hernandez MD, Sousa AB, et al. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab 2010;95:E58-E63
9. Agarwal AK, Xing C, DeMartino GN, et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010;87:866-872
10. Lupsa BC, Sachdev V, Lungu AO, Rosing DR, Gorden P. Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment. Medicine (Baltimore) 2010;89:245-250
11. Musso C, Javor E, Cochran E, Balow JE, Gorden P. Spectrum of renal diseases associated with extreme forms of insulin resistance. Clin J Am Soc Nephrol 2006; 1:616-622
12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372: 425-432
13. Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010;53:27-35
14. Bingham A, Mamyrova G, Rother KI, et al.; Childhood Myositis Heterogeneity Study Group. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) 2008;87:70-86
15. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med 2012;33:35-45
16. Zeve D, Tang W, Graff J. Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell 2009;5:472-481